Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185492 · ClinicalTrials.gov registry record
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
A clinical trial of Acute Myocardial Infarction and Cardiogenic Shock, sponsored by Stavros G Drakos.
- Recruiting
- Registry status
- 500
- Enrollment target
- 3
- Study locations
NCT05185492: Recruiting study of Acute Myocardial Infarction and Cardiogenic Shock, sponsored by Stavros G Drakos.
NCT05185492 is a study of Acute Myocardial Infarction and Cardiogenic Shock that is actively recruiting participants, run by Stavros G Drakos. The registered enrollment target is 500 participants, below the 1,856-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05185492, a study of Acute Myocardial Infarction and Cardiogenic Shock, is actively recruiting participants, sponsored by Stavros G Drakos.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at these institutions will provide valuable insight into the factors associated with adverse outcomes; and will serve as a blueprint for future clinical trial designs that may better inform clinical practice.
Primary Outcome
Percentage of participants alive at analysis time points
Conditions Studied
Study Locations (3)
Florida
- Cleveland Clinic Florida - Weston
Virginia
- Inova Heart and Vascular Institute - Falls Church
Ontario
- University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2027-12-31 |
What NCT05185492 shows while recruiting
NCT05185492 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,856-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT05185492 reports a single indexed study location in Florida, Virginia, Ontario.
Frequently Asked Questions
What is clinical trial NCT05185492 about?
NCT05185492 is a clinical study titled "Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock". This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care cent...
What is the current status of trial NCT05185492?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-05-25. Estimated completion is 2027-12-31.
What conditions does trial NCT05185492 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction, Cardiogenic Shock.
Who is sponsoring clinical trial NCT05185492?
This trial is sponsored by Stavros G Drakos, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05185492 being conducted?
This trial has 3 study locations across Florida, Virginia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05185492's enrollment target sits among peer trials
500 9th of 19 higher than 11 of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
-
Molecular and Morphologic Characterization of Circulating Endothelial Cells
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI